Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
83 studies found for:    Open Studies | "Anticoagulants"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Anticoagulants"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown  Reversal of the Antithrombotic Action of New Oral Anticoagulants
Conditions: Thrombosis;   Anticoagulant-induced Bleeding;   Anticoagulant Overdosage;   Hemorrhage
Interventions: Drug: Rivaroxaban;   Drug: Dabigatran
2 Not yet recruiting Influence of ABCB1 Polymorphisms on Plasma Concentrations of New Oral Anticoagulants in Case of Serious Adverse Events
Conditions: Anticoagulants;   Thromboembolism;   Hemorrhage
Interventions: Other: Measurement of Plasma Concentrations of NOACs;   Genetic: Identification of ABCB1 polymorphisms coding for P-gp
3 Not yet recruiting Measuring the Incidence of Hospital Readmissions Based on Adverse Drug Events
Conditions: Incidence of Readmissions;   ADE's Due to Anticoagulants
Intervention:
4 Recruiting Comparison of Antithrombotic Treatments After Aortic Valve Replacement. Rivaroxaban: A New Antithrombotic Treatment for Patients With Mechanical Prosthetic Aortic Heart Valve.
Conditions: Aortic Valve Disease;   Heart Valve Prosthesis Implantation;   Anticoagulants
Intervention: Drug: Rivaroxaban
5 Recruiting Pharmacoepidemiology Treatment of Symptomatic Pulmonary Embolism in Hospitalized Patients Aged 75 Years or More: Prospective, Multicenter Cohort Study PEAGE
Conditions: Elderly;   Pulmonary Embolism;   Anticoagulants
Intervention: Other: 4 blood samples
6 Recruiting Perioperative Anticoagulant Use for Surgery Evaluation Study
Condition: Atrial Fibrillation
Intervention:
7 Unknown  Anticoagulant Treatments and Percutaneous Coronary Angioplasty
Condition: Coronary Artery Disease
Interventions: Drug: clopidogrel + aspirin;   Drug: heparin + clopidogrel + aspirin;   Drug: enoxaparin + clopidogrel + aspirin;   Drug: bivalirudin + clopidogrel + aspirin
8 Recruiting Novel Oral Anticoagulants in Stroke Patients
Conditions: Ischemic Stroke,;   Intracranial Hemorrhage,
Intervention:
9 Recruiting Therapy With New Oral Anticoagulants
Conditions: Atrial Fibrillation;   Non-valvular Atrial Fibrillation
Intervention:
10 Recruiting Observatory of Invasive Procedures and Bleeding in Patients Treated With New Oral Anticoagulants
Conditions: Venous Thromboembolism;   Atrial Fibrillation
Intervention: Other: complications and compliance with GIHP recommendations
11 Recruiting Patent Foramen Ovale Closure or Anticoagulants Versus Antiplatelet Therapy to Prevent Stroke Recurrence
Conditions: Ischemic Stroke;   Patent Foramen Ovale;   Atrial Septal Aneurysm;   Migraine
Interventions: Drug: aspirin;   Drug: Antivitamins K;   Device: Devices for PFO closure
12 Recruiting Outpatient Treatment of Low-Risk Venous Thromboembolism With Target Specific Anticoagulant
Condition: Venous Thromboembolism
Intervention:
13 Unknown  Benefits of a Comprehensive Patient Education on Oral Anticoagulant Compared to Conventional Hospital Education
Condition: Cardiac Surgery
Interventions: Behavioral: VKA (antivitamin K) education;   Behavioral: conventional hospital education
14 Unknown  rFVIIa in ICH in Patients Treated With Anticoagulants or Anti-Platelets
Condition: Intracerebral Hemorrhage
Interventions: Drug: rFVIIa + (vit K in AO patients);   Drug: FFP or aPCC+ vit K in AO treated patients
15 Recruiting Intracerebral Hemorrhage Due to Oral Anticoagulants: Prediction of the Risk by Magnetic Resonance
Condition: Ischemic Stroke
Intervention: Drug: oral anticoagulants
16 Not yet recruiting Benefit/Risk in Real Life of New Oral Anticoagulants and Vitamin K Antagonists in Patients Aged 80 Years and Over
Condition: Atrial Fibrillation
Interventions: Drug: Direct oral antocoagulant: dabigatran, rivaroxaban, apixaban;   Drug: Vitamin K antagonist: warfarin, fluindione, acenocoumarol
17 Recruiting Echo-Doppler Assessment of the Occurrence of Asymptomatic DVT in Orthopedic Replacement Surgery Under Enoxaparin
Conditions: Deep Vein Thrombosis;   Venous Thrombosis;   Anticoagulants
Intervention: Drug: Enoxaparin
18 Not yet recruiting A Clinical Study of Lyophilized Plasma in Patients on Warfarin
Condition: Anticoagulant Therapy
Interventions: Biological: Lyophilized Plasma;   Biological: Licensed Plasma
19 Unknown  Determination of Residual Anticoagulatory Effects of Fondaparinux
Condition: Anticoagulant Prophylaxis/Therapy
Intervention:
20 Unknown  Monitoring Anticoagulant Therapy in Antiphospholipid Syndrome
Condition: Antiphospholipid Syndrome
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years